Effect of diphenylhydantoin on the metabolism of metyrapone and release of ACTH in man.
D015065:17-Hydroxycorticosteroids / Q000097:blood / Q000652:urine; D000324:Adrenocorticotropic Hormone / Q000097:blood / Q000378:metabolism*; D003864:Depression, Chemical; D004827:Epilepsy / Q000188:drug therapy; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D007408:Intestinal Absorption; D008797:Metyrapone / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism*; D006899:Mixed Function Oxygenases / Q000037:antagonists & inhibitors; D010672:Phenytoin / Q000494:pharmacology* / Q000627:therapeutic use; D011749:Pyrogens / Q000494:pharmacology; D014316:Tritium
D015065:17-Hydroxycorticosteroids; D011749:Pyrogens; D014316:Tritium; D010672:Phenytoin; D000324:Adrenocorticotropic Hormone; D006899:Mixed Function Oxygenases; D006854:Hydrocortisone; D008797:Metyrapone